Receive monthly emails about the latest oncology research and technology, new patient services, resources and more!

Please select an option below to help us tailor your newsletter to best suit your content interests!

No thanks

Lung Cancer: Chaired by Jason Porter, MD


Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of lung cancer.


  • Jason Porter, MD | West Cancer Center & Research Institute
  • Wade T. Iams, MD | Vanderbilt-Ingram Cancer Center
  • Ramakrishna Battini, MD | West Cancer Center & Research Institute
  • David C. Portnoy, MD, FACP | West Cancer Center & Research Institute


  • Frontline SCLC
  • Second Line SCLC
  • Targeting EGFR in Lung Cancer
  • Other Targetable Alterations (RET, METex14, BRAF, HER2)